Dr Maggie Cheang have extensive multidisciplinary experience in cutting-edge fields including biomedical sciences, cancer genomics (bioinformatics), pathology and clinical trials. Her main research focus is in the molecular classification of tumours and the development of multi-parametric (multi-modal) genomics assays by integrative analyses and to identify clinically relevant biomarkers that can be used as intermediate biological endpoints for phase II (platform) trials for targeted therapies. Dr Cheang currently leads a multidisciplinary research group of statistical, computational and translational scientists, strategically within the Clinical Trials and Statistics Unit at The Institute of Cancer Research, to develop novel and efficient computational analytical methods for the application of high-dimensional multi-omics data generated from bio-specimens collected in clinical trials.